Universe Pharmaceuticals (UPC) Equity Average (2021 - 2025)
Universe Pharmaceuticals' Equity Average history spans 5 years, with the latest figure at $50.8 billion for Q3 2025.
- On a quarterly basis, Equity Average rose 123.22% to $50.8 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $50.8 billion, a 123.22% increase, with the full-year FY2025 number at $50.8 billion, up 38.33% from a year prior.
- Equity Average hit $50.8 billion in Q3 2025 for Universe Pharmaceuticals, up from $22.8 billion in the prior quarter.
- Over the last five years, Equity Average for UPC hit a ceiling of $50.8 billion in Q3 2025 and a floor of $33.9 million in Q3 2021.
- Historically, Equity Average has averaged $17.1 billion across 5 years, with a median of $15.8 billion in 2023.
- Biggest five-year swings in Equity Average: surged 52103.81% in 2022 and later decreased 20.86% in 2024.
- Tracing UPC's Equity Average over 5 years: stood at $33.9 million in 2021, then surged by 52103.81% to $17.7 billion in 2022, then dropped by 20.84% to $14.0 billion in 2023, then skyrocketed by 62.51% to $22.8 billion in 2024, then soared by 123.22% to $50.8 billion in 2025.
- Business Quant data shows Equity Average for UPC at $50.8 billion in Q3 2025, $22.8 billion in Q3 2024, and $14.0 billion in Q1 2024.